PharmaBoardroom & Focus Reports Sponsor ETIF 2014
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
IVAX Argentina, member of the Teva Group, is one of the leading companies in the local pharmaceutical industry, Teva. Permanent growth is driven by more than 46,000 employees in 60 countries.
In Argentina, IVAX offers products and services of excellence for healthcare and improving the quality of life of human beings.
Our products are designed to treat a wide range of pathologies, highlighting the cardiometabolic, neurological and psychiatric, osteoarticular and muscular system, oncology, HIV, onco-urological diseases, gastroenterological and hepatológicas. The Company offers a line of women’s health for different indications.
Among the main products COPAXONE is leading the world market (Glatiramer Acetate) for the treatment of Multiple Sclerosis. Committed to the quality of life of patients, the company has a program of care for patients with Multiple Sclerosis: Shared Solutions, designed to provide information and control to all patients treated with Copaxone.
The company produces and sells about 120 drug products in more than 250 trade shows.
Address: Juan José Castelli 6701 – B1652ACM – Villa Adelina – Province of Buenos Aires – Argentina
Patients and health professionals:
0800-666-3342 info@ivax.com.ar
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
Gabriela Pittis discusses the Argentinian healthcare system’s ability to diagnose, treat, and regulate rare diseases, and the country’s progress in further developing what is already the region’s most comprehensive system…
The director general of the Argentina, Uruguay and Paraguay region for Sanofi discusses the strength of the Argentinian healthcare system and the key, but subdued, role that multinational pharmaceutical companies…
The general manager of Argentia weighs up the factors that have led to his company consolidating its different business lines and becoming one of the fastest growing companies in Argentina.…
Hugo Sigman explains how understanding problems in the same way as opportunities helped his company to become what is today, a successful Argentinian conglomerate where life and science is the…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
Bioceres manages investments in agricultural biotechnology and related sciences. The company’s CEO, Federico Trucco, discusses the potential of Argentina’s biotech scene to become a world-class drug developer in biopharma as…
See our Cookie Privacy Policy Here
